Editas Medicine (EDIT) Treasury Shares (2015 - 2025)

Editas Medicine (EDIT) has 11 years of Treasury Shares data on file, last reported at $595730.0 in Q4 2025.

• Treasury Shares for Q4 2025 came in at $595730.0, down 74.39% year-over-year; the trailing twelve-month figure through Dec 2025 was $595730.0 (down 74.39% YoY), and the FY2025 annual result was $595730.0, down 74.39% from the prior year.
• Treasury Shares retreated to $595730.0 in Q4 2025 per EDIT's latest filing, from $652267.0 in the prior quarter.
• Over five years, Treasury Shares peaked at $2.7 million in Q1 2024 and troughed at $595730.0 in Q4 2025.
• A 5-year average of $1.5 million and a median of $1.5 million in 2022 frame the typical range for Treasury Shares.
• The sharpest annual moves came in 2022 and 2025: Treasury Shares surged 138.43% in 2022, then tumbled 74.39% in 2025.
• A 5-year view of Treasury Shares shows it stood at $628732.0 in 2021, then surged by 138.43% to $1.5 million in 2022, then soared by 40.56% to $2.1 million in 2023, then advanced by 10.41% to $2.3 million in 2024, then plunged by 74.39% to $595730.0 in 2025.
• Business Quant data shows EDIT's Treasury Shares at $595730.0 in Q4 2025, $652267.0 in Q3 2025, and $923539.0 in Q2 2025.